OasisLMS

September 25, 2025, 6pm Eastern

	J. Dawn Abbott, MD, MSCAI Moderator		Mila Kovačević, MD, PhD Longterm Clinical Impact of Angiographic Complexity in LM Trifurcation Percutaneous Coronary Interventions
	Gautam Kumar, MBBS, FSCAI Case: LM Trifurcation in AMI Cardiogenic Shock		Imad Sheiban, MD, FSCAI Case: Step-by-Step Approach of LM Trifurcation Stenting
	Mariem Sawan, MD Panelist

• Assess and apply procedural techniques to treat bifurcation lesions
• Examine imaging modalities and their best applications
• Discuss challenging bifurcation cases

As a provider of continuing medical education through the Accreditation Council for Continuing Medical Education (ACCME), it is the Society’s policy to ensure balance, independence, objectivity, and scientific rigor in all its activities.

Planning Process 
SCAI activities are developed by the SCAI planners prior to and independent of commercial support. Members of the Education Committee reviewed and approved this activity. If planners had relevant financial relationships, the agenda was peer reviewed by a member with no relevant financial relationships.

Content Validation Statement
SCAI accepts the following Content Validation Statements and expects all persons involved in its professional education activities to abide by these statements for clinical care recommendations.

All clinical and pharmacological recommendations are based on evidence accepted within the medical profession as adequate jurisdiction for their indications and contradictions in patient care. SCAI does not promote recommendations, treatment, or manners of practicing medicine that are not within the definition of accredited continuing education or known to have risks or dangers that outweigh the benefits or known to be ineffective in the treatment of patients.

All research referenced to support or justify patient care recommendations conforms to accepted standards of experimental design, data collection and analysis. 

SCAI actively promotes improvements in health care and NOT proprietary interests of an ineligible company. SCAI's educational content is free of marketing or sales of products or services.

Faculty will not actively promote or sell products or services that serve their professional or financial interests during accredited education. 

SCAI encourages faculty to identify investigational products or off-label uses of products regulated by the U.S. Food and Drug Administration (FDA), at first mention and where appropriate in the content.